Evidence map›Paper›PMID 19535900›Full record

ArticleCell cycle (Georgetown, Tex.)2009

Effects of p21 deletion in mouse models of premature aging.

Erica K Benson, Bo Zhao, David A Sassoon, Sam W Lee, Stuart A Aaronson

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Repurposing Cell Cycle Oscillators for Multiciliated Cell Differentiation.Advances in experimental medicine and biology · 2026
    Review
  2. CDKN1A/p21 in Breast Cancer: Part of the Problem, or Part of the Solution?International journal of molecular sciences · 2023
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Erica K BensonDepartment of Oncological Sciences, Mount Sinai School of Medicine, New York, NY 10029, USA.
Bo Zhao
David A Sassoon
Sam W Lee
Stuart A Aaronson
Computer Emergency Response Team · FRIcahn School of Medicine at Mount Sinai · US

Funding

PW1--A mediator of cell survival by NFKB and cell death by p53P01CA080058 · NCI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI AARONSON, STUART A · 2000 to 2016
$20.2M
NCI NIH HHS P01 CA080058NCI NIH HHS P01CA80058
6 · The paper itself

Abstract

An approach to investigate the role of cellular senescence in organismal aging has been to abrogate signaling pathways known to induce cellular senescence and to assess the effects in mouse models of premature aging. Recently, we reported the effect of loss of function of p21, a gene implicated in p53-induced cellular senescence, in the background of the Ku80(-/-) premature aging mouse (Zhao et al., EMBO Rep 2009). Here, we provide an overview of the effects of p21 deletion in different models of premature aging.

Indexed as

Aging, PrematureAnimalsAntigens, NuclearAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsCellular SenescenceCyclin-Dependent Kinase Inhibitor p21DNA-Binding ProteinsGene Knockout TechniquesKu AutoantigenMiceMice, KnockoutProtein Serine-Threonine KinasesRNATelomeraseTumor Suppressor Protein p53Antigens, NuclearAtaxia Telangiectasia Mutated ProteinsAtm protein, mouseCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p21DNA-Binding ProteinsKu AutoantigenProtein Serine-Threonine KinasesRNATelomerasetelomerase RNATumor Suppressor Protein p53Tumor Suppressor ProteinsXrcc6 protein, mouse

Identifiers

PMID19535900
PMCPMC5839167
OpenAlexW2089409641

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.